Rubio-Camacho, M.; Encinar, J.A.; MartÃnez-Tomé, M.J.; Esquembre, R.; Mateo, C.R.
The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug. Biomolecules 2020, 10, 1015.
https://doi.org/10.3390/biom10071015
AMA Style
Rubio-Camacho M, Encinar JA, MartÃnez-Tomé MJ, Esquembre R, Mateo CR.
The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug. Biomolecules. 2020; 10(7):1015.
https://doi.org/10.3390/biom10071015
Chicago/Turabian Style
Rubio-Camacho, Marta, José A. Encinar, MarÃa José MartÃnez-Tomé, RocÃo Esquembre, and C. Reyes Mateo.
2020. "The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug" Biomolecules 10, no. 7: 1015.
https://doi.org/10.3390/biom10071015
APA Style
Rubio-Camacho, M., Encinar, J. A., MartÃnez-Tomé, M. J., Esquembre, R., & Mateo, C. R.
(2020). The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug. Biomolecules, 10(7), 1015.
https://doi.org/10.3390/biom10071015